Renewed hope for treatment of spinal and bulbar muscular atrophy?

被引:0
|
作者
Dengler, Reinhard [1 ]
机构
[1] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany
来源
LANCET NEUROLOGY | 2010年 / 9卷 / 09期
关键词
LEUPRORELIN;
D O I
10.1016/S1474-4422(10)70186-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:845 / 846
页数:2
相关论文
共 50 条
  • [1] Developing treatment for spinal and bulbar muscular atrophy
    Fischbeck, Kenneth H.
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 257 - 261
  • [2] Spinal and Bulbar Muscular Atrophy
    Grunseich, Christopher
    Fischbeck, Kenneth H.
    NEUROLOGIC CLINICS, 2015, 33 (04) : 847 - +
  • [3] IGF-1 for spinal and bulbar muscular atrophy: hope and challenges
    Hashizume, Atsushi
    Katsuno, Masahisa
    LANCET NEUROLOGY, 2018, 17 (12): : 1026 - 1027
  • [4] Treatment of spinal and bulbar muscular atrophy with leuprorelin acetate
    Yamamoto, Tomotaka
    Ohtsu, Hiroshi
    Tsuji, Shoji
    ANNALS OF NEUROLOGY, 2007, 62 : S68 - S68
  • [5] Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
    Tanaka, Fumiaki
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Adachi, Hiroaki
    Sobue, Gen
    NEURAL PLASTICITY, 2012, 2012
  • [6] Dutasteride for spinal and bulbar muscular atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Sobue, Gen
    LANCET NEUROLOGY, 2011, 10 (02): : 113 - 115
  • [7] Spinal and Bulbar Muscular Atrophy Overview
    Fischbeck, Kenneth H.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 317 - 320
  • [8] Spinal and Bulbar Muscular Atrophy Overview
    Kenneth H. Fischbeck
    Journal of Molecular Neuroscience, 2016, 58 : 317 - 320
  • [9] Progress toward the development of treatment of spinal and bulbar muscular atrophy
    Sahashi, Kentaro
    Hashizume, Atsushi
    Sobue, Gen
    Katsuno, Masahisa
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 503 - 514
  • [10] Anti-androgen Treatment for Spinal and Bulbar Muscular Atrophy
    Fischbeck, Kenneth H.
    Bryan, Wilson W.
    ANNALS OF NEUROLOGY, 2009, 65 (02) : 119 - 120